Vaccine News and Research

Latest Vaccine News and Research

Finding potential microRNAs from humans and plants against SARS-CoV-2

Finding potential microRNAs from humans and plants against SARS-CoV-2

New collaboration aims to boost vaccines manufacturing capability in South Africa

New collaboration aims to boost vaccines manufacturing capability in South Africa

Interim recommendations for use of recombinant COVID-19 vaccine updated to reflect latest evidence

Interim recommendations for use of recombinant COVID-19 vaccine updated to reflect latest evidence

Bus stop by bus stop, Denver-area officials microtarget vaccine hesitancy

Bus stop by bus stop, Denver-area officials microtarget vaccine hesitancy

Amid covid booster debate, West Virginia to check immunity of vaccinated nursing home residents

Amid covid booster debate, West Virginia to check immunity of vaccinated nursing home residents

BNT162b2 vaccine shows high efficacy at six months

BNT162b2 vaccine shows high efficacy at six months

Prior SARS-CoV-2 infection enhances Johnson and Johnson Ad26.COV2.S vaccine immunogenicity

Prior SARS-CoV-2 infection enhances Johnson and Johnson Ad26.COV2.S vaccine immunogenicity

Cash vouchers provide greater incentive for COVID-19 vaccines than lotteries

Cash vouchers provide greater incentive for COVID-19 vaccines than lotteries

Scientists suspect Lambda SARS-CoV-2 variant most dangerous

Scientists suspect Lambda SARS-CoV-2 variant most dangerous

Phase 1/2 trial results for Nanocovax, protein subunit SARS-CoV-2 vaccine from Vietnam

Phase 1/2 trial results for Nanocovax, protein subunit SARS-CoV-2 vaccine from Vietnam

Study explains how SARS-CoV-2 variants differ in binding to ACE2 receptor

Study explains how SARS-CoV-2 variants differ in binding to ACE2 receptor

Study reveals cellular basis of antigen-specific response to Pfizer-BioNTech’s COVID-19 vaccine

Study reveals cellular basis of antigen-specific response to Pfizer-BioNTech’s COVID-19 vaccine

Study supports UK’s decision to extend second COVID-19 vaccination to 12 weeks

Study supports UK’s decision to extend second COVID-19 vaccination to 12 weeks

KHN’s ‘What the Health?’: Hot covid summer

KHN’s ‘What the Health?’: Hot covid summer

Multibillion dollar crusade to eradicate polio appears to have come to an end

Multibillion dollar crusade to eradicate polio appears to have come to an end

99% of COVID-19 deaths in Italy occur among those not fully vaccinated

99% of COVID-19 deaths in Italy occur among those not fully vaccinated

Prior SARS-CoV-2 infection enhances effectiveness of Pfizer-BioNTech vaccine

Prior SARS-CoV-2 infection enhances effectiveness of Pfizer-BioNTech vaccine

NIH scientists demonstrate efficient aerosol transmission of SARS-CoV-2 in hamsters

NIH scientists demonstrate efficient aerosol transmission of SARS-CoV-2 in hamsters

SARS-CoV-2 Beta variant marginally affects Pfizer vaccination efficacy in fully vaccinated

SARS-CoV-2 Beta variant marginally affects Pfizer vaccination efficacy in fully vaccinated

Spike-containing virus-like particles induce robust sterilizing immunity against SARS-CoV-2 in macaques

Spike-containing virus-like particles induce robust sterilizing immunity against SARS-CoV-2 in macaques

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.